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Abbreviations
AA: atrial activation
AF: atrial fibrillation
AS: analytic signal
CT: computed tomography
DF: dominant frequency
EAM: electroanatomic mapping
ECG: electrocardiogram
EGM: electrogram
FIRM: focal impulse and rotor modulation
HT: Hilbert transform
LA: left atrium
LAAT: local atrial activation timing
LGE-MRI: late-gadolinium enhancement
MRA: magnetic resonance angiography
MRI: magnetic resonance imaging
NDSR: negative derivative sinusoidal recomposition
PS: phase singularity
PV: pulmonary veins
RFCA: radiofrequency catheter ablation
SEGM: synthetic electrogram
SR: sinusoidal recomposition
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TE: echo-time
TR: recovery time
VA: ventricular activation
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Abstract
Atrial fibrillation is the most common type of arrhythmia encountered in clin-
ical practice but its maintaining mechanisms remain elusive. Radiofrequency
catheter ablation is a non-pharmacological therapy that aims to restore sinus
rhythm ablating tissue that facilitates atrial fibrillation perpetuation and is more
effective than medications. Neverthless, rigorous monitoring after the ablation
procedures showed atrial fibrillation recurrence in about 40% to 60% of cases
for one procedure and in about 70% of cases for three or more procedures.
Over the last years, theories based on the structural and electrical remodeling
have been proposed to target atrial fibrillation mechanisms.
It is well known that the hallmarks of the structural changes during atrial fibril-
lation are the fibrosis tissue generation and left atrium dilatation. According to
recent studies, the success rate of the ablation procedure and the induction of
atrial fibrillation depends on the atrial fibrotic tissue extent on the atrial wall.
Other studies ascribe the ablation failure to left atrium enlargement occurring
during the arrhythmia.
One of the theories on atrial electrical remodeling in atrial fibrillation, strongly
debated in the Electrophysiology Community, is the “Rotor Theory”. Recently,
a study guided by a proprietary navigation system, showed the presence of sta-
ble electrical rotors whose ablation may improve the outocome of the ablation
procedure. Other studies did not confirm these results.
The aim of this thesis is to provide computational approaches to better investi-
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gate the existence of the electrical rotors and the role of the left atrium structural
alterations as potential primary mechanisms sustaining atrial fibrillation.
The thesis is composed by four chapters. The first chapter introduces the atrial
fibrillation and describes in details the electrical rotor and the structural re-
modeling phenomena identified as possible maintaining mechanisms for atrial
fibrillation.
The second chapter regards the structural characterization of the left atrium
through the development of a fully-automated approach for 3D left atrium fi-
brosis patient specific model construction and left atrium volume estimation. In
this chapter are presented several imaging techniques that were applied on mag-
netic resonance imaging data. In particular, in oder to obtain the 3D left atrium
patient-specific model, a new fully-automated approach for the left atrium seg-
mentation on magnetic resonance angiography is described and a multimodality
affine registration, used to superimpose the fibrosis information derived from the
late-gadolinium enhancement on the 3D model, is presented. In addition several
techinques for the fibrosis quantification are showed in details. Furthermore, for
the left atrium volume estimation, an approach able to remove the pulmonary
veins from the 3D left atrium model is designed and the qualitative and quanti-
tative results on fibrosis extent and left atrium volume computation are showed.
The third chapter regards the electrical characterization of the left atrium
throught the development of an independent approach for the rotor localization
on 3D left atrium surface based on the phase analysis of the unipolar electro-
grams. In particular a new version of the sinusoidal recomposition method for
local atrial activation detection and for phase map construction is described and
a rotor detection algorithm based on the phase singularity concept is described.
The chapter also exhibits the development of a synthetic electrogram generator,
used for testing of the local atrial activation detection, and the validation of
the rotor localization using an atrial computational model. The results of the
validations are illustrated in details and in addition the results on clinical data
are presented. Furthermore, this chapter shows the analysis conducted and its
results on the influence of the spatial coverage of the catheter on rotor localiza-
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tion.
Finally in the fourth chapter some conclusive remarks are presented with pos-
sible future developments of the presented work.
Overall this PhD project wants to provide a better understanding the mecha-
nisms promoting the initiation, progression and maintenance of atrial fibrillation
through the development of imaging and signal processing computational ap-
proaches.
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Abstract
Il progetto di Dottorato presentato si colloca nell’ambito della fibrillazione atri-
ale, la quale risulta essere una delle aritmie maggiormente riscontrate nella prat-
ica clinica. Nel corso degli ultimi anni si sono sviluppate metodiche che hanno
consentito di trattare la fibrillazione atriale mediante ablazione transcatetere
con radiofrequenza, terapia che si e` dimostrata molto efficace nel ripristino del
ritmo sinusale, eliminando il tessuto responsabile dell’aritmia stessa. Nonostante
l’ablazione sia una delle terapia piu` promettenti per la fibrillazione atriale, la
percentuale di successo dopo una singola procedura di ablazione resta del 40%-
60%, circa del 70% dopo tre o piu` procedure. Tali percentuali suggeriscono che i
meccanismi che regolano e sostengono la fibrillazione atriale non sono ancora ben
compresi e pertanto una strategia ablativa ottimale non e` ancora disponibile.
A tal proposito si sono sviluppate diverse teorie sui meccanismi alla base della
fibrillazione atriale basate sul rimodellamento strutturale ed elettrico dell’atrio
sinistro.
E` risaputo che i cambiamenti strutturali dell’atrio sinistro durante l’aritmia
sono attribuibili alla generazione del tessuto fibrotico sulla parete atriale e alla
dilatazione dell’atrio sinistro. Secondo studi recenti, il tasso di successo delle
procedure di ablazione, cos`ı come la generazione della fibrillazione atriale, dipen-
dono dalla percentuale di tessuto fibrotico sulla parete; altri studi adducono
il fallimento dell’ablazione ad un aumento delle dimensioni dell’atrio sinistro,
causato dall’aritmia stessa.
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Una delle teorie sul rimodellamento elettrico dell’atrio, fortemente discussa nella
comunita` scientifica di elettrofisiologia, e` la ”teoria dei rotori”. Uno studio
molto recente, ha dimostrato la presenza di “rotori” o “onde a spirali” stabili
nello spazio, la cui ablazione incrementa notevolmente la percentuale di successo
della procedura. Studi successivi condotti da altri gruppi di ricerca, non hanno
confermato la presenza di rotori.
Lo scopo di questo lavoro di tesi e` quello di investigare il ruolo dei rotori elet-
trici e delle alterazioni strutturali dell’atrio sinistro come potenziali meccanismi
responsabili della generazione e del sostentamento della fibrillazione atriale.
La tesi e` strutturata in quattro capitoli. Il primo capitolo introduce la fibril-
lazione atriale e descrive nel dettaglio i rotori elettrici e i fenomeni alla base del
rimodellamento strutturale, identificati come possibili responsabili del sostenta-
mento della fibrillazione atriale.
Il secondo capitolo riguarda la caratterizzazione strutturale dell’atrio sinistro at-
traverso lo sviluppo di un metodo completamente automatico atto alla costruzione
di un modello 3D paziente-specifico della fibrosi dell’atrio sinistro e alla stima
della volumetria atriale. In questo capitolo vengono presentate le diverse tec-
niche di imaging, applicate su dati di risonanza magnetica e utilizzate per la
generazione del modello 3D. In particolare, viene descritto un nuovo metodo
completamente automatico per la segmentazione dell’atrio sinistro a partire da
immagini di risonanza magnetica angiografica ed e` stato utilizzato un metodo
di registrazione affine multimodale per sovrapporre l’informazione sulla fibrosi
ottenuta dai dati di risonanza magnetica con il late gadolinium enhancement
sul modello 3D ricostruito. Inoltre nel capitolo sono mostrate diverse tecniche
di quantificazione della fibrosi e viene presentato anche un nuovo approccio per
la rimozione delle vene polmonari dal modello 3D dell’atrio. Infine vengono
presentati i risultati qualitativi e quantitativi della volumetria atriale stimata e
della distribuzione del tessuto fibrotico sulla parete atriale.
Il terzo capitolo riguarda la caratterizzazione elettrica dell’atrio sinistro at-
traverso lo sviluppo di un approccio indipendente per la localizzazione dei ro-
tori sulla superficie 3D dell’atrio sinistro, basato sull’analisi in fase degli elet-
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trogrammi unipolari. In particolare, viene presentata una nuova versione del
metodo di ricomposizione sinusoidale, per una migliore detezione degli istanti
di attivazione atriale e per una ricostruzione 3D della mappe di fase piu` accu-
rata.
La seconda parte del capitolo si focalizza sulla descrizione dell’algoritmo di de-
tezione dei rotori basato sul concetto di singolarita` di fase. Inoltre viene presen-
tato lo sviluppo di un generatore di elettrogrammi sintetici, usato per testare la
detezione degli istanti di attivazione atriale, e la validazione della localizzazione
dei rotori attraverso l’utilizzo di un modello computazionale dell’atrio sinistro.
Vengono presentati nel dettaglio i risultati delle validazioni ed i risultati ottenuti
sui dati clinici. Inoltre questo capitolo mostra l’analisi condotta e i risultati ot-
tenuti sull’importanza della copertura spaziale del catetere nella localizzazione
dei rotori.
Nel quarto capitolo sono presentate delle osservazioni conclusive e possibili
sviluppi futuri del presente lavoro.
In generale questo progetto di dottorato ambisce a fornire una migliore com-
prensione dei meccanismi relativi all’innescamento, alla progressione e alla per-
sistenza della fibrillazione atriale attraverso lo sviluppo di nuovi metodi basati
sull’elaborazione di immagini di risonanza magnetica e di segnali intracavitari.
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Chapter 1
Introduction
AF is the most common type of cardiac arrhythmia characterized by an irreg-
ular and rapid beating of the atria.
Despite big efforts to improve AF efficacy, its therapies remain suboptimal be-
cause the maintaining mechanisms of AF are not clearly identified. In this
regards, over the last years, various theories were proposed to improve the out-
come of AF treatments.
1.1 AF: epidemiology and clinical implications
AF is the leading cause of hospitalization and death [1]. Despite good progress
in the management of patients affected by AF, this arrhythmia remains one
of the major causes of stroke, heart failure, sudden death and cardiovascular
morbidity in the world [2].
In 2010, the estimated number of the individuals with AF worldwide was 33.5
million (20.9 million males and 12.6 million females), with the higher incidence
in developed countries [3, 4]. The Cardiovascular Heart Study showed that the
age-specific prevalence is higher in men than women and this difference becomes
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equal in older age. The prevalences in the age group 65– 69 years were 5.8% and
2.8% in men and women, respectively; and in the age group 70 –79 years, the
prevalence was almost equal in men and women: 5.9% and 5.8%, respectively,
due to the longer life expectancy in women [5, 6]. In Europe over 4.5 million of
people are affected by AF and in 2030 the expected number will be 14-17 million
with the number of new cases of AF per year of 120.000 - 215.000 [4, 7, 8]. In
US people affected by AF are 3 millions [9]. The prevalence of AF increases
with the age. It is 1% in the general population and increases from 0.1% among
adults younger than 55 years to 9% among octogenerians. Approximately 70% of
individuals with AF are between 65 and 85 years of age. Apart from advancing
age, other risk factors for AF are: hypertension, diabetes mellitus, valvular
heart disease and congestive heart failure [5, 10]. Hospitalization is the primary
cost driver in the management of AF and the economic burden is nontrivial [11].
Some studies have identified annual costs for AF in 2005 of 6.65 million dollars
in US and 459 million pounds in UK [12, 13]. These costs with the increasing
prevalence justify increased attention to the management of patients with AF.
In AF, heart electrical signals do not begin in the sinoatrial node, but in other
part of the atria, especially near the ostia of the PVs. The signals spread
throughout the atria in a rapid and disorganized way, causing their fibrillation.
Patients with AF, may have no symptoms (asymptomatic AF) or suffer of a
variety of symptoms including: palpitations or a fluttering heartbeat, irregular
heartbeat, chest pains, dizziness and fainting spells (Figure 1.1) .
Chaotic electrical activation in the atria associated with AF, manifests in the
ECG as undistinguishable P waves due to the asynchronous depolarization of
atrial tissue. Atrial rates detected from the ECG in AF vary between 400-600
“beats” per minute (bpm). In some cases the pattern of atrial activity can
be similar to atrial flutter, mostly regular and with high amplitude, or both.
During AF, the RR intervals is commonly irregular, varing in a range 110-180
bpm [14]. Fortunately, the atrioventricular node does not allow many signals
through to the ventricles; about 1 or 2 out of every 3 atrial activations passes to
the ventricles (Figure 1.2). According to AF duration, success of cardioversion
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Figure 1.1: Electrical pathway in sinus condition (left) and in atrial fibrilla-
tion (right).
Figure 1.2: ECG signals in sinus rhythm (top) and AF condition (bottom).
techniques and capacity of restarting, five different types of AF are traditionally
distinguished [2, 15, 16]:
• First diagnosed: AF that has not been diagnosed before, irrespective of
the duration of the arrhythmia or the presence and severity of AF-related
symptoms.
• Paroxysmal AF: self-terminating in most cases within 48 hours. Some
AF paroxysms may continue for up to 7 days. AF episodes that are
cardioverted within 7 days should be considered paroxysmal.
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• Persistent AF: AF that lasts longer than 7 days, including episodes that
are terminated by cardioversion, either with drugs or by direct current
cardioversion, after 7 days or more.
• Long-standing persistent AF: continous AF lasting for ≥ 1 year when it
is decided to adopt a pharmacological rhythm control strategy.
• Permanent AF: AF that is accepted by the patient (and physician). Hence,
rhythm control interventations are, by definition, not pursued in patients
with permanent AF. Should a rhythm control strategy be adopted, the
arrhythmia would be re-classified as ‘long-standing persistent AF’.
The therapies for AF management consist of pharmacological and non-
pharmacological treatments. Antiarrhythmic drugs can be used for rate control
of chronic atrial fibrillation, cardioversion of atrial fibrillation to sinus rhythm,
maintenance of sinus rhythm after the cardioversion. Antiarrhythmic drugs
comprise many different drug classes and have several different mechanisms of
action. Furthermore, some classes and even some specific drugs within a class
Figure 1.3: Vaughan-Williams classification
are effective with only certain types of arrhythmias. The first scheme that was
proposed for drug administration, the Vaughan-Williams classification, is still
the most used in clinical practice. [17], (Figure 1.3). Antiarrhythmic drug
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action is usually insufficient by itself and it often requires application of the
non-pharmacological therapies in order to restore the sinus rhythm. Reasons
for choosing non-pharmacological therapy may be paroxysmal atrial fibrilla-
tion with very frequent attacks and severe symptoms, chronic atrial fibrillation
without adequate rate control, leaving the patient at risk of developing tachy-
cardiomyopathy, or patients who experience intolerable side effects of otherwise
effective drug therapy [18]. Non - pharmacological treatments include electri-
cal shock therapy (also known as defibrillation or cardioversion), implanting a
short-term heart pacemaker or RFCA.
1.2 RFCA
Catheter ablation of AF is a non-pharmacological therapy more effective than
medications. It consists in of an invasive procedure that aims to restore the
sinus rhythm by eliminating tissue causing AF with radiofrequency energy. The
procedure is carried out in the Electrophysiology lab using fluoroscopy and a
3D EAM system. The 3D navigation system combines anatomic and electri-
cal information by a catheter point-by-point mapping, allowing a 3D anatomic
reconstruction of a 3D shell of the targeted cardiac chamber (Figure 1.4a).
There are two different EAM systems that are widely used in clinical practice.
The CARTO mapping system (Biosense Webster Inc., NJ, USA) relies on both
a magnet-based localization for visualization of the ablation catheter and an
impedence-based system that allows for both tip and catheter curve visualiza-
tion as well as simultaneous visualization of multiple electrodes. The second one
is an electrical impedence mapping system (NavX, St. Jude Medical Inc., MN,
USA) using voltage and impedence for localization. Recently, a third EAM
avaible in clinical practice is the magnetic and electrical Rhythmia mapping
system (Boston Scientific, MA, USA), which is an EAM system that allows for
automated high density mapping using a dedicated 64-electrodes mini basket
catheter [19].
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The use of these 3D mapping systems has been demonstrated to reduce fluo-
roscopy duration [20, 21].
To improve the anatomical accuracy of the map, integration of 3D images ob-
tained by CT or MRI has become available. Despite CT and MRI are not
real-time images and their registration with the navigation system spatial do-
main might be not accurate, some studies sustain that the use of EAM system
with the image integration improves the safety and the efficacy of the ablation
procedure [22, 23, 24].
More than 15 years ago, Haissaguerre et al. [25] revealed ectopic beats from
the PVs may trigger AF, establishing the field of AF ablation with PV isolation
as its cornerstone. The ablation consists of a series of point -by-point radiofre-
quency lesions encircling the ostia of the PVs using the ablation catheter inserted
through the femoral vein (Figure 1.4b), [26]. Cryoablation is another technique
Figure 1.4: a) Electroanatomical map; b) 3D reconstruction of the LA with
circumferential ablation lesions (red points) arround the ostia pf the PVs
developed as a tool for AF ablation. Cryoablation systems work by delivering
liquid nitrous oxide under pressure through the catheter to its tip or within
the balloon, where it changes to gas, resulting in cooling of surrounding tissue.
This gas is then carried back through the reciprocating vacuum lumen. The
mechanism of tissue injury results from tissue freezing with a creation of ice
crystals within the cell that disrupts cell membranes and interrupts both cellu-
lar metabolism and any electrical activity in that cell [27]. A study conducted
in 2016 [28] reported no differences in efficacy and patient safety between the
two kind of ablations.
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Electrical isolation of the PVs is recommended during all AF ablation proce-
dures. Despite the importance of this ablation endpoints, AF recurrence rate,
observed especially in patients with persistent AF, remains high. PV isolation
conveys a 60-80% rate of maintaining sinus rhythm after 1 year in patients with
paroxysmal form of AF and about 50-60%in patients with persistent AF [29]. A
study published by Ganesan et al. [30] demonstrated that the single procedure
success for paroxysmal AF was 68.6% at 1 year, 61.1% at 3 years and 62.3%
at 5 years. Comparing patients with persistent and long-standing persistent
AF after a single procedure the results were less favorable, 50.8% at 1 year,
and 41.6% at 3 years. This percentages suggest the maintaining mechanisms of
AF are still unclear or partially known especially for the persistent AF. In this
regards, recently, new insights on structural and electrical remodeling of LA
during AF and additive strategies to the PV isolation were proposed to target
AF mechanisms.
1.3 LA remodeling in AF
AF results from continuous remodeling of the LA, which involves electrical and
structural remodeling transformations. These transformations are associated
with the arrhythmia but they are also associated with the age and genetic
factors. Electrical remodeling primarly reduces the refractory period and the
action potential duration of the atria, while the structural remodeling impedes
propagation and decreases the conduction velocity [31], promoting cell death,
fibroblast proliferation and excess extracellular matrix production leading to
fibrosis. Fibrotic lesions, preventing the electrical propagation, may favor the
generation of reentry, as well as fibroblast-cardiomyocyte interactions promote
reentry and ectopic impulse generation. On the other hand, AF itself may
promote the structural alterations, creating a loop that contributes to the AF
sustenance [32]. However, whether or not structural abnormalities observed in
the atria are cause or consequence of AF, remains an open question. Another
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aspect is the atrial enlargement that is probably associated with fibrosis gener-
ation. Atrial size was shown to be an important risk factor for AF recurrence
[33] after the ablation and with the fibrotic tissue represents the core processes
involved in structural remodeling.
1.3.1 Structural remodeling
Structural remodeling of the LA is characterized by fibrotic tissue generation
and atrial enlargement. Fibroblasts represent an integral part of function-
ing myocardium by providing a cellular scaffold, maintaining a proper three-
dimensional network required for normal mechanical function and contributing
to the uniformity of the excitable substrate and to the uninterrupted and rapid
propagation of electrical activation through the myocardium [34]. In addition
to that, fibroblasts play an important role in the regulation of cardiomyocyte
function by slowing down conduction in response to mechanical stretch [35], and
in pathological conditions associated with AF, fibroblasts may proliferate, dif-
ferentiate to myofibroblasts and increase production of extracellular matrix [36].
As a result of fibrosis development, the architecture of fibrotic myocardial tissue
becomes heterogeneous, thereby affecting intercellular conduction [37] increas-
ing its anisotropy and leading to conduction slowing, development of functional
and structural block, thus creating the arrhythmic substrate [38].
Chronic animal models provide the opportunity to study the relationship be-
tween the fibrotic tissue and AF. A study conducted using a rapid atrial pacing
(RAP)-induced chornic AF in dogs, demonstrated that the fibrosis increases
both in the atrium and in the ventricle. The percentage of fibrosis in a control
dog was about 2.0%, 10.1% after six months of AF dogs. The study also ob-
served the presence of the fibrosis in the LV : 1.0% in a control dog, 2.4% after
six months (Figure 1.5) [39].
LGE-MRI is a recent technique used for LA fibrosis distribution assessment on
the atrial wall. LGE-MRI is capable of visualizing micro-fibrosis that cannot be
detected by other imaging techniques and is performed about 15 minutes after
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Figure 1.5: A) LA sample from control dog. B) LA sample after 6 months AF
dogs. C) LV sample from control dog. D) LV sample after 6 months. E) The
fibrosis increases both in the atrium and ventricle. The number indicates the
SDs [39]
.
injection of the contrast agent, minimum time after which the healthy tissue
eliminates the contrast medium and appears dark. The damaged cells instead
appear bright white because their elimination of the contrast medium is lower
(Figure 1.6). However, LGE acquisition has a main limitation: the lack of stan-
dardized image acquisition protocol. LA wall image intensity on LGE-MRI is
affected by parameters such as surface coil proximity, contrast dose, delay time
of image acquisiton after contrast injection and individual characteristics such
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Figure 1.6: Example of a LGE-MRI acquisition. The bright region represents
the fibrotic tissue on the atrial wall.
as the body mass index, renal function and haematocrit. All these technical
variables can affect comparison across centres, and together with the absence of
standardized image processing protocol, can lead to different results. Another
problem is the image resolution and the thickness of the atria wall. While ven-
tricular fibrosis assessment has achieved excellent results using MRI, the chal-
lenge of atrial fibrosis assessment remains open because of the limited image
resolution, the atrial wall thickness and the unpredictable shape of the LA wall
[40]. Therefore, a reliable and reproducible method to locate and quantify mio-
cardial fibrosis in atrium is still lacking. In recent years, several groups tested
the ability of LGE-MRI to detect both pre-existing fibrosis and post-ablation
scarring [41, 42]. DECAAF study conducted by the CARMA Center, reported
that extent of fibrosis my predict recurrences after the ablation procedure and
therefore the information about the fibrosis exent may help the electrophysiol-
ogist in patient’s selection for the ablation procedure [43].
It was a multicenter, prospective, observational cohort study of patients affected
by paroxysmal and persistent AF (undergoing their first catheter ablation) con-
ducted in 15 centers: in USA (6), Australia (1) and Europe (8). LGE-MRI
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images were acquired up to 30 days before the procedure. Data acquisition was
performed during the LA diastole. The other scan parameters for LGE-MRI at
3T were: voxel size=1.25x1.25x2.5 mm, TR=3.1 ms, TE=1.4 ms, flip angle=14
degrees. The same parameters for LGE-MRI acquired at 1.5T were: voxel size=
1.25x1.25x2.5 mm, TR=5.2 ms, TE=2.4 ms, flip angle=20 degrees. Each of the
participating centers followed their regular clinical protocol for contrast injec-
tion for cardiac MRI.
A 3D LA patient-specific model with fibrosis distribution was obtained from
the manual segmentation of the endocardial and epicardial borders. The man-
ual tracings were achieved by an expert directly from the LGE-MRI (Figure 1.7).
The fibrosis was quantified using a thresholding algorithm on grey-intensity level
and it was based on image’s histogram by estimating the mean and the standard
deviation of “normal” tissue. “Normal” tissue was defined as the lower region
of the pixel intensity histogram between 2% and 40% of the maximum intensity
within the region of interest (e.g., the LA wall). The enhanced/fibrotic thresh-
old was then calculated as two to four standard deviations above the mean of
“normal.” The threshold was estimated for each patient individually and the
threshold was estimated slice by slice [44].
According to the fibrosis percentage, patients were classified in four groups
(Figure 1.8) and the study reported the patients classified in the fourth group
presented AF recurrence after the ablation procedure. The DECAAF study was
the first multicenter study demonstrating the feasibility and potential clinical
value of the LGE-MRI in the management of patients with AF and considered
for ablation.
As mentioned in section 1.2 of this chapter, another non-invasive predictor factor
of the AF recurrence is the LA enlargement. Although the casual relationship
between AF and LA dilation remains controversial, it is well recognized LA
enlargement is related to the presence of AF in both patients with structural
heart disease and those with lone AF [45].
Some studies [46, 47, 48] have demonstrated that an enlarged LA measured
by echocardiography, MRI, or CT, predicts the AF recurrence after the RFCA
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Figure 1.7: Implemented workflow for the 3D LA fibrosis model contruction.
LGE-MRI acquisition (step 1). Atrial wall manually segmented (step 2). Wall
segmentation includes the 3D extent of both the LA wall and the antral re-
gions of the PVs. Quantification of fibrosis is based on relative intensity of
contrast enhancement (step 3). The 3D model is rendered from the endocar-
dial and wall segmentations and the maximum enhancement intensities are
projected on the surface of the model (step 4).
and, more recent recommendations include LA size criteria for patient’s selec-
tion for the ablation procedure [15]. The most widely used linear dimension
is the LA anteroposterior measurement in the parasternal long-axis view us-
ing M-mode echocardiography or, preferably, 2D echocardiography [49, 50, 51].
Although this measurement has been used extensively in clinical practice and
research, it has become clear that frequently it may not represent an accurate
picture of LA size. Traditionally, the anteroposterior dimension was widely
used because it was known to be the most reproducible measurement. However,
assessment of LA size using only the anteroposterior diameter assumes that
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Figure 1.8: 3D rendering of the LA in four patients classified according the
Utah classification. The blue region represents the healty tissue, the green and
white regions the fibrotic changes. The fibrosis is expressed as a percentage of
the total atrial wall volume.
when the left atrium enlarges, all its dimensions change similarly, which is often
not the case during LA remodeling. When assessing the LA size and remod-
eling, the measurement of LA volume is recommended. Evaluation of volume
takes into account alterations in LA chamber size in all directions [49, 52, 53].
Three-dimensional echocardiography holds promise for assessing LA volume and
correlates with CT and MRI but the lack of a standardized methodology and
limited normative data [54] are limitations to the use of 3D echocardiography.
1.3.2 Electrical remodeling
Atrial electrophysiological properties are governed by ion channels, pumps and
exchangers, any of which can be altered by atrial remodeling. The principal
components of electrical remodeling identified to date include decreased L-type
Ca2+ current, rectifier background K+ current and constitutive acetylcholine-
regulated K+ current and abormal expression (and distribution) of the gap junc-
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tion connexin hemichannels that connect cardiomyocites electrically [55]. These
electrophysiological changes are responsible for initiation and maintenance of
AF mechanisms.
There are three main hypotheses regarding the generation and maintenance of
AF:
• Multiple reentrant wavelets [56]: AF is perpetuated by continuous con-
duction of several independent wavelets propagating through the atria in
a chaotic manner (Figure 1.9 A).
• Focal hypothesis [25]: AF is maintained by high frequency focal source
near the ostia of the PVs. Fibrillatory conduction is generated when
the wavefronts become fractionated and disorganized among the hetero-
geneous atrial tissue (Figure 1.9 B).
• Rotor hypothesis [57]: AF is generated and maintained by a stably ro-
tating pattern (electrical spiral waves) that surrounds a pivot point (Fig-
ure 1.9 C).
The rotor theory was recently proposed by Narayan et al. [57]. The CON-
FIRM study was conducted using a 2D rudimental electroanatomical mapping
system (RhythmView system, Abbott, ILL, USA) and using the 64-pole basket
catheter (Constellation, Boston Scientific Inc., MA,USA). The Constellation
catheter, considering the typical size used in clinical practice (diameter: 60
mm, covered area: 117 cm2, intra-electrode spacing: 5 mm), once opened, is
able to privide real-time mapping in just one heart cycle, acquiring simultaneous
longitudinal and circumferential signals (Figure 1.10). The study enrolled 107
patients with paroxysmal and persistent AF. The subjects were divided in two
groups: FIRM-guided group (36 patients) and FIRM-blinded group or conven-
tional ablation (71 patients).
Electroanatomical AF maps were obtained during all procedures using the
CARTO and NavX system; electrical rotors were localized using the Rhyth-
mView system (Figure 1.11). The study showed FIRM ablation was able to
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Figure 1.9: A) Multiple reentrant wavelets. B) Focal hypothesis. C) Rotor
theory.
Figure 1.10: Constellation catheter (left). RhythmView system (right).
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Figure 1.11: Disorganized right atrium during AF (left). LA rotor (white ar-
row) with counterclockwise activation (red to blue) (right).
terminate or consistentely slow persistent and paroxysmal AF before any con-
ventional ablation in 86% of patients and substantially increase long-term AF
elimination compared to the conventional ablation. The AF termination was
obtained in 20/36 patients. By comparison, in the FIRM-blindend group, the
acute endpoint was achieved in 20% of patients and AF termination in 6/65
patients. The CONFIRM trial demonstrated for the first time that human AF
may be sustained by stable (in time and in space) electrical rotors whose abla-
tion my improve the outcome of the ablation procedure.
Nowadays, the rotor identification as a possible targets for AF mechanisms and
their stability, remain controversial. Recent studies [58, 59] demonstrated the
presence of meandering rotors on the space with a very short persistance in time,
other studies [60, 61] conducted with the high density mapping didn’t confirm
the presence of the rotors.
Another aspect not yet clarified is the role of high DF sites in the maintenance
of AF. DF is the frequency occuring most often in a signal and it correspondes
to the frequency where the power spectral density is maximum. In persistent
AF, DF values vary in a range of [3-15] Hz. A study conducted by Sanders
at al. [62], indentified sites of high frequency activity during AF with different
distribution in paroxysmal and permanent AF whose ablation may improve the
30
success rate of the RFCA. The study comprised 32 patients undergoing AF ab-
lation (19 paroxysmal, 13 permanent). The DF values were estimated for each
EGM acquired by the mapping catheter during the ablation and the 3D DF
maps were constructed. The high DF sites were defined as the maximal fre-
quencies surrounded by a decreasing frequency gradient ≥ 20% (Figure 1.12).
The spatial distribution of the high DF sites in paroxysmal patients were located
Figure 1.12: A) 3D DF maps in patient with paroxysmal AF. High DF sites
are located in each PV. B) 3D DF maps in patient with permanent AF. The
maximal atrial frequency (DF) is higher than the paroxysmal case. Many high
DF sites are located outside the PVs.
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within the PVs, whereas in the permanent AF, the sites were more prevalent
and located both inside and outside the PVs. The study demontrated the ab-
lation of the high DF sites resulted in a slowing and termination of paroxysmal
AF in 87% of patients, confirming the role of localized sites of high frequency in
the maintenance of AF. However, patients with permanent AF did not benefit
from the DF site ablation.
1.4 Aim of the thesis
The aim of the thesis is the development of computational approaches to inves-
tigate the underlying mechanisms of AF, not yet clearly identified. In particular
the PhD project is focused on a) a fully-automated approach for fibrosis quantifi-
cation and LA volume estimation and on b) the development of an independent
approach to examine the presence of the drifting and fast rotors that could rep-
resent the drivers of AF. Of the three main theories previuosly described about
the electrical characterization of the LA in AF, this PhD thesis is focused on
the electrical rotors theory, which is nowadays one of the more debated topics
in the electrophysiological community.
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Chapter 2
Structural characterization
of the LA in AF
This chapter describes the studies carried out on the structural remodeling of
the LA during AF and it is divided in two sections. In the first one, the new
fully-automated approach implemented for the atrial volumetric characteriza-
tion is illustrated and the results on its validation are described. The second
section is focused on the automated assessment of the atrial fibrosis through the
development of a 3D patient-specific LA model that integrates the anatomical
and structural information and the use of several approaches for the fibrosis
quantification. The implemented method was tested on the MRI data provided
by the CARMA Center through a free access website.
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2.1 Development of 3D patient-specific model
for LA volumetric analysis to support ab-
lation in AF patients
Content of this first section is based on the article “3D patient-specific models
for left atrium characterization to support ablation in atrial fibrillation patients”
by Maddalena Valinoti, Claudio Fabbri, Dario Turco, Roberto Mantovan, An-
tonio Pasini, Cristiana Corsi (Magnetic Resonance Imaging, 45:51-57,2018).
2.1.1 Introduction
It is well known that atrial enlargement is a common consequence of AF and
may facilitate the induction and perpetuation of AF. Both LA diameter and
volume were previously studied to determine the accuracy for LA enlargement
assessment.
Over the last decade, a series of studies [63, 64] have been performed to as-
sess the relationship between LA anteriorposterior diameter estimated with
transthoracic 2D echocardiography and AF recurrence after RFCA. These stud-
ies showed inconsistent results. Abecasis et al. [65] demonstrated that LA
volume was related to the outcome of radiofrequency ablation, whereas the
diameter was not. LA diameter is often asymmetric and oriented predomi-
nantly in superior-inferior and medial-lateral direction underestimating the LA
enlargement [66, 67]. Therefore, accurate assessment of LA volume using a
three-dimensional imaging modality might be essential for the improvement of
AF patient selection for RFCA.
Another aspect is the influence of the 3D LA reconstruction on the ablation
outcome. Previous studies on the 3D LA reconstruction reported LA geometry
is essential for RFCA ablation safety and efficacy. In the clinical setting, 3D
geometries are usually obtained by a point by point EAM resulting in a rough
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anatomical model of the LA including PVs. The construction of the EAM is
a time-consuming, potentially imprecise and cumbersome procedure [68, 69].
Nowadays several navigation systems allow to import data from MRI or CT for
a more reliable 3D LA reconstruction [70]. Both CT and MRI provide accurate
anatomical LA reconstruction; however, image processing for the extraction of
the 3D LA surface is manual and relies on operator expertise. In addition, with
respect to CT imaging, MRI acquisition does not emit ionizing radiation and
could provide additional information on fibrotic tissue on the atrial wall [71]. In
this scenario, a patient-specific LA anatomical model derived from MRI, includ-
ing a better identification of PVs, could assist RFA procedure. In addition, the
availability of such 3D model could also provide additional informations related
to patient selection for RFCA procedure, as the atrial volume.
Accordingly, this study aimed at developing a unified, fully automated approach
to build a 3D patient-specific LA model including PVs in order to provide an
accurate anatomical guide during RFCA and a 3D patient-specific LA model
without PVs in order to characterize LA volumetry and support patient selec-
tion for AF ablation, from MRI.
2.1.2 Materials and methods
Study population and MRI acquisition The study was approved by the
Ethics IRST, IRCCS AVR Committee (CEIIAV n. 1456 prot. 6076/2015
I.5/220). Twenty-six patients referred for AF RFCA were included in the study.
Informed consent was obtained from all the subjects. The main clinical char-
acteristics of patients are summarized in Table 2.1. Images were acquired with
a 1.5 T MRI scanner (Achieva, Philips Medical System) and a 3D spoiled gra-
dient recalled sequence was applied. Contrast enhanced 3D MRA images were
acquired (echo time: 1.12 ms, repetition time: 3.74 ms, flip angle: 25◦, in-plane
resolution 0.7 x 0.7 mm and slice thickness 3 mm, with 1.5 mm overlap) with
gadolinium injection of 0.1 mmol/kg followed by a 20 ml saline flush. Acquisi-
tion was ECG triggered and in breath hold.
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Patient
ID
Sex Age
Weight
[kg]
Height
[cm]
LA size from TEE before RFA Follow-up (time)
1 M 58 78 175 Normal No Recurrence (15 mo)
2 M 61 61 181 Normal No Recurrence (10 mo)
3 M 63 75 170 LA slightly enlarged No Recurrence (18 mo)
4 M 61 73 160 LA slightly enlarged* AF (1 mo)
5 M 71 87 170 LA slightly enlarged No Recurrence (12 mo)
6 M 50 86 178 LA slightly enlarged** No Recurrence (24 mo)
7 M 66 105 193 LA slightly enlarged AF (3 mo)
8 M 52 78.5 178 LA slightly enlarged No Recurrence (24 mo)
9 M 57 90 177 LA slightly enlarged*** No Recurrence (11 mo)
10 M 56 83 173 LA slightly enlarged Flutter (3 mo)
11 M 57 98 165 Normal No Recurrence (4 mo)
12 F 62 74 175 Normal No Recurrence (11mo)
13 M 56 88 165 Normal No Recurrence (3 mo)
14 M 73 82 180 LA slightly enlarged**** AF (12 mo)
15 M 67 81 177 Normal AF (1 mo)
16 F 64 62 172 Normal No Recurrence (15 mo)
17 M 60 68 179 Normal No Recurrence (3 mo)
18 M 75 86 175 LA area 23 cm2 No Recurrence (11 mo)
19 M 47 89 187 LA slightly enlarged***** No Recurrence (1 mo)
20 M 63 90 180 Normal No Recurrence (14 mo)
21 M 60 82 180 Normal AF (1 mo)
22 M 55 87 167 Normal No Recurrence (4 mo)
23 M 51 80 165 Normal No Recurrence (3 mo)
24 M 60 90 174 LA dilated No Recurrence (3 mo)
25 M 70 85 178 LA slightly enlarged No Recurrence (1 mo)
26 F 61 78 163 Normal No Recurrence (3 mo)
Table 2.1: Patients’ characteristics from medical records; *AP diameter 39
mm, area 26 cm2, volume 89 ml; **AP diameter 42 mm, area 20 cm2, volume
26 ml; ***AP diameter 44 mm, area 29 cm2, volume 100 ml; ****AP diame-
ter 46 mm, area 29 cm2, volume 100 ml; *****AP diameter 45 mm.
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MRA data processing The fully automated workflow for 3D patient-specific
LA model with and without PVs is shown in Figure 2.1. The first step was the
Figure 2.1: Workflow of the developed approach for 3D patient specific LA
model with and without PVs. Left panel: final detected contour in a 2D MRA
image; middle panel: 3D patient-specific LA model including PVs; right panel:
3D patient-specific model without PVs.
segmentation of the LA from MRA images (Figure 2.2, a). The proposed method
is based on a 2D edge-based level set approach [72] guided by a phase–based edge
detector. The differential equation that guides the evolution of the zero level of
the level set function (φ) is composed by the smoothing term, the baloon term
(or expansion term) and the advection term, that attracts the curve towards
the edge of the image.
∂Φ
∂t = g(K − 1)∇Φ + v∇Φ∇g
Φ(x, y, t) = min(Φ0)
Φ(x, y, 0) = Φ0(x, y)
ν, >0
where g is the edge indicator, gK∇Φ represents the smoothing term, g∇Φ is the
expansion term, ν∇Φ∇g is the advection term. The novelty of the implemented
approach is the edge indicator, which is based on the feature asimmetry (FA)
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Figure 2.2: Description of the fully automated segmentation algorithm. a) An
example of the MRA image. b) Result of the Otsu’s method application. c)
Isolation of the atrium from the other regions after the application of morpho-
logical operators and considering the atrium size end its position in the image.
According to the MRA acquisition protocol, the images are acquired in frontal
view and the atrium is always located in the center of the acquired images.
In our approach, we took advantages from this standard procedure and the
atrium is automatically selected as the region with the centroid closer to the
center of the image. d) The initial condition of the level set function is auto-
matically built considering the contour of the selected region. e) Result of the
application of the segmentation algorithm.
containing the phase information of the image.
g = 1− FAα
where α=1.5
FA is obtained by the monogenic signal (fm(x,y,z)), which is an extension in
N - dimension of the AS [73]. The monogenic signal is a complex signal derived
by summing to the signal (f(x,y,z)), its Riesz’s transform (fR).
fm(x, y) = even+ i ∗ odd
Riesz’s transform provides the imaginary components of the monogenic sig-
nal that is obtained applying odd quadrature filters. The expression of FA is
obtained from the output of the filters and represents the phase congruency
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(Figure 2.3).
FA =
|odd| − |even| − T√
even2 + odd2 + 
 > 0
T is a corrective costant number used to reduce the noise and artifacts, odd
and even are the output of the filters. This method is characterized by a high
robustness to the noise than the classic level set approach, whose edge indicator
is based on the grey intensity level gradient. The initialization of the level
Figure 2.3: Phase information in each direction (N-domain). The red dot rep-
resents the phase congruency.
set function was obtained by applying Otsu’s method [72] resulting in a rough
detection of LA boundaries (Figure 2.2, b). The atrium was automatically
selected applying morphological operators and considering the size of the atrium
and its position in the image (Figure 2.2, c).
The distance function of the selected region was built and its zero level was used
as the initial condition (Figure 2.2, d) for the evolution of the level set function.
The final detected contour represents the LA endocardial boundaries including
the PVs (Figure 2.2, e).
This last step also allowed to exclude the left ventricle from the final boundaries.
This approach was automatically applied to all 2D MRA acquired slices in which
LA was visible. From the collection of 2D detected LA contours including the
PVs, the 3D patient-specific LA model was obtained (Figure 2.4).
According to the American Society of Echocardiography [49] to compute the
LA volume, PVs were removed from the 3D surface previously obtained by the
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Figure 2.4: An example of 3D patient-specific LA model derived from the seg-
mentation step. Top panel: 2D detected LA contours including the PVs. Bot-
tom panel: 3D patient-specific LA surface derived from the segmented MRA
images.
segmentation method. For this purpose the shape diameter function (SDF) was
estimated.
The SDF is a scalar function defined on the mesh surface that measures the
corresponding local object diameter. For each facet, several rays are sampled
in a cone constructed using the centroid of the facet apex and inward-normal of
the facet as axis. Each ray is truncated into a segment, its endpoints being the
apex of the cone and the first mesh facet intersection point. Using the weighted
average lengths of these truncated rays, which intuitively correspond to a local
volume sampling, the raw SDF value is computed (Figure 2.5). The SDF was
calculated for each facet of the 3D surface using the CGAL software (Figure 2.6,
a). Based on the histogram of the SDF we computed the optimal threshold in
order to obtain a semantic clusterization of our 3D model.
This step allowed to identify the PVs, Auricola, LA chamber and Mitral valve
(Figure 2.6, b) By considering the information about PVs anatomical position,
they were automatically identified and removed from the surface (Figure 2.6,
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Figure 2.5: Shape diameter function. Several rays are sampled inside the
cone. The lengths of the rays inside the atrial chamber are longer than ones
inside the cavity (PVs, Auricola, Mitral valve).
Figure 2.6: Workflow developed for the PVs identification and removal. a)
SDF estimation for each facet of the 3D mesh; b) Clusterization step based on
a SDF thresholding; c) Identification of the PVs considering their anatomical
position on the 3D surface; d) PVs removal.
c).
2.1.3 Statistical analysis and results
The normality distribution of variables was tested using Kolmogorov-Smirnov
test. All variables were not normal. Depending on the distribution, continu-
ous variables were expressed as mean±standard deviation or median and in-
terquartile range. Paired variables were compared using the Kruskal–Wallis
test. P<0.05 was considered significant. One experienced investigator manually
segmented LA chamber without the PVs in the MRA images of all subjects.
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In order to perform manual contouring, an in-house toolbox for manual seg-
mentation was implemented. To investigate the intra-observer variability of the
manual segmentation, the analysis was repeated twice by the same investigator
two months after the first tracing in 10 randomly selected patients. For each
patient, the automatic segmentation results were compared with the manual
segmentation in terms of surface-to-surface distance, computed as the average
distance (in mm) of each automatically detected surface point to reference sur-
face. In addition, LA volume estimates were compared with LA reference volume
values by linear regression and Bland-Altman analysis. The intra-observer vari-
ability expressed in percentage, was assessed as the ratio between the difference
between the two estimates and their mean value. The automatic algorithm and
the toolbox for manual segmentation were developed in Matlab environment (v.
R2016a, Mathworks, Natick, MA).
Automatic segmentation was feasible in all study subjects. Time required for
the analysis was about 4 min for the 3D LA model with PVs and about 8 min for
the 3D LA model without PVs on a 2.5 GHz, Intel Core i5 computer with 8 GB
RAM. Median LA volume was 92.5 ml (ICQ (interval quartile range): 84–100
ml) from manual analysis and 92.3 ml (ICQ: 85–99 ml) from the automated
approach. Qualitative comparison between the obtained 3D LA models with
the point by point maps was performed and the result reported in Figure 2.7
highlights PVs reconstruction was not accurate and left atrial appendage is
missing. An example of the 3D patient-specific LA models with (grey surface)
and without (red surface) PVs superimposed is shown in Figure 2.8. In Fig-
ure 2.9 the comparison between manual and automated LA boundary detection
in one acquired slice is illustrated. Results of the regression and Bland-Altman
analyses between LA volume estimates and corresponding references are shown
in Figure 2.10 (y=1.03x-1.4; r=0.99; bias: -1.37 ml corresponding to -1.43%;
SD: 54.3 ml; mean percentage difference was -1.3%±2.1%; mean percentage ab-
solute difference resulted in -1.9%±1.6%). The surface-to-surface distance was
2.3%±0.7% mm. The intra-observer variability was 2.7%±3.9% for the manual
tracing performed by the expert radiologist. Since no manual interaction is re-
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. Considering our experience in the EP lab, most of AF ablation procedures
are guided by 3D LA models obtained applying semi-automatic segmentation
algorithms on CT or MRI acquisitions. An accurate reconstruction of the LA
using the point-by-point mapping is still time consuming considering the pro-
cedural time duration.
Figure 2.7: Comparison between the EAM and the 3D patient-specific LA
surface. a) EAM reconstructed by the navigation system during the ablation
procedure. b) 3D patient-specific LA model derived from the segmented data.
quired for the computation of the 3D LA models, LA volumes did not change
when the analysis was repeated.
Figure 2.8: Overlapping between the 3D LA surface with PVs (grey) and
without PVs (red).
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Figure 2.9: Comparison between manual (green) and automated left (red)
atrial boundaries detection.
Figure 2.10: Comparison between the volumes estimated with the automated
approach with ones estimated by manual tracing (MT). Results of the regres-
sion (a) and Bland-Altman analysis (b).
2.1.4 Discussion and conclusions
In AF patients, an accurate 3D patient-specific model could assist RFCA im-
proving ablation outcome and, at the same time, provide quantitative informa-
tion regarding LA volumetry which is predictive of AF recurrence. The present
study proposes a unified and fast workflow allowing computation of 3D patient-
specific LA models (with and without PVs) useful to support patient selection
for RFCA and a reliable guidance during the therapy. A local segmentation
approach based on an image phase-driven information was combined with a re-
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gion based initialization for the level set evolution. The implemented method
was effective and provided reliable 3D LA patient-specific models even in pres-
ence of large morphological variations, as expected considering LA anatomy.
Preliminary comparison between EAMs and the 3D patient-specific LA mod-
els with PVs showed the latter are able to better describe LA anatomy. The
possibility of mapping the information acquired during the ablation procedure
(electrograms or EGMs and voltages) on a realistic 3D patient-specific anatomy
provides a better understanding of the conduction properties of the tissue.
A detailed description of the LA anatomy especially in correspondence of PVs
that represent the main target of RFA and are geometrically complex structures
difficult to be accurately acquired by a point by point mapping, would allow the
correct location of EGMs and voltage information on the LA wall and conse-
quently may help in optimizing the selection of ablation sites and in evaluating
RFCA acute efficacy and safety. An accurate LA anatomy would also facilitate
LA navigation and thus reducing fluoroscopic time during RFCA.
Quantitative assessment of LA volume resulted in accurate and reliable esti-
mates that are not affected by observer variability. Manual and automatic LA
segmentation were in high agreement and slight differences in LA volumes com-
putation were found applying the two techniques. As a standard procedure, LA
volumes computed from manual segmentation were used as reference values to
evaluate our approach. Obviously we cannot exclude inaccuracies in manual
segmentation and to limit their influence, tracings were performed by an expert
radiologist. In addition, to quantify this potential source of error we computed
intra-observer variability. LA segmentation is a challenging task due to high
variability in LA anatomy.
The proposed approach for LA volume computation is fully automated and no
prior information is required. The first step of the segmentation provides a
3D LA patient-specific-model with PVs whose inclusion is mandatory for abla-
tion guidance and voltage or activation mapping. The detection and removal
of PVs detection is required for LA volume computation. Indeed, PVs removal
from 3D patient-specific model was effective, since results on studied popula-
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tion show volume computation is accurate with tight limits of agreement and
small percentage errors. Only few approaches have been proposed in literature
for LA volume quantification; these approaches are semi-automatic and require
operator corrections [65, 74, 75]. The segmentation technique proposed by Tao
[76] is based on a multiatlas dictionary by manual annotation of LA chamber
and PVs. Following the multiatlas creation, the LA segmentation of a specific
patient is automatic. The method requires 15 min to compute the 3D LA vol-
ume compared to 4 min of our approach. In both cases, the methods can be
applied oﬄine since no manual interaction is required. A very recent study
[77] proposed a hybrid approach for fully automatic segmentation of the LA
from cardiac volumetric MRI. Random forests for tissue classification followed
by an active contour evolution for segmentation refinement were applied to ob-
tain an accurate LA model with PVs. Final segmentation outperforms other
methods reported in literature but computational time is about 7.5 h mainly
due to random forest parallel training. The new approach showed comparable
performance, slightly minor (surface to surface: 1.14±1.21 mm) with a com-
putational time compatible with clinical application. In this study data from
MRI were used. Advantages on the use of MR data versus CT and echo have
been reported elsewhere showing echocardiography underestimates LA volume
compared to other imaging modalities [74, 78]. The majority of studies [75, 79]
aimed at LA volume quantification in AF patients used data from CT imaging
and only very few studies [76] were carried out using MR images. As previ-
ously reported in [76] the use of MRA data improves segmentation accuracy
and robustness without significantly affecting acquisition time and allowing the
additional acquisition of late gadolinium enhanced images (LGE-MRI) from
which fibrotic tissue information is readily available. Nowadays, several authors
[80] proposed an atrial fibrosis-based approach for AF ablation, making this ac-
quisition technique crucial in this specific clinical setting. The proposed 3D LA
model with PVs could be easily integrated with fibrosis information by simply
registering the two datasets and using grey-level intensities from LGE-MRI as a
texture of the 3D anatomical model. LA volume has been shown to be a useful
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index to identify patients in whom successful AF ablation can be achieved [65].
This volumetric index was proven to be associated with presence and chronicity
of AF, differently from LA diameter [78, 81]. Therefore an accurate method
to quantify LA enlargement seems pivotal in AF risk stratification. The pro-
posed 3D patient-specific models for LA characterization to support ablation in
AF patients has several limitations. The study population is comparably small
and further validation on a large number of patients should be performed. The
hypothesis that a more realistic LA anatomy detection could improve RFCA
procedure, should be verified by the integration of the 3D patient-specific LA
model from MRA with EGMs and voltage information acquired during ablation
procedure. In addition, post RFCA quantitative data to evaluate a possible
correlation between LA volume and RFCA outcome were not available.
2.2 LA fibrotic tissue assessment
Recently, LGE–MRI has been proposed to optimize AF diagnosis and treatment
through the assessment of atrial fibrosis, which is considered an arrhythmogenic
substrate. Several studies [43, 82] have suggested both extensive atrial tissue
fibrosis and association between scar gaps and PV reconnection sites as possible
causes of the poor outcomes of the AF catheter ablation. In order to assist
the electrophysiologist in patient selction and ablation procedure planning, an
automated approach for 3D visualization of the fibrotic tissue extent and its
quantification was developed. For this purpose, LGE-MRI data were acquired
on the twenty-six patients (Table 3.1) and the grey intensity levels were su-
perimposed on the reconstructed 3D LA model obtained segmenting the MRA
images. Finally, different methods were used for the fibrosis quantification and
for patients’ classification and the obtained results were compared in order to
investigate if Utah classification may depends on the method applied to quantify
the fibrosis extent.
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2.2.1 Materials and methods
The LGE-MRI data were acquired with the same scanner used for the MRA ac-
quisitions. 3D MP-inversion recovery with fat saturation was applied (echo time:
3.20 ms; repetition time: 6.52 ms; flip angle: 22◦, 3 mm thick, 1.5 mm overlap
in-plane axial spatial resolution: 0.95 mm; scan time: 15-20 min depending on
HR and respiration). The images were acquired 15 min after contrast injection.
An example of the DE-MRI image is shown in the Figure 2.11. The structural
Figure 2.11: Example of an acquired LGE-MRI image.
remodeling information derived from LGE-MRI data was superimposed on the
3D LA model applying a multimodality affine registration on the data based
on mutual information (MI) as a similarity measure (Figure 2.12) [83, 84, 85].
More specifically, the MRA images were registered in the spatial domain of the
LGE-MRI and the estimated affine matrix was then used to register the 3D LA
patient-specific model in the LGE-MRI spatial domain (Figure 2.13). Before
the registration, the axial view of the MRA images was reconstructed.
The corresponding intensity grey level information derived from the LGE-
MRI (Figure 2.14, (a)) was used as a texture (Figure 2.14,(c)) on the registered
3D surface LA model obtained from the MRA segmentation (Figure 2.14,(b)),
allowing the 3D visualization of LA fibrosis location and extent (Figure 2.14,(d)).
The 3D model obtained is able to provide the real fibrosis tissue distribution
and its extension on the wall.
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Figure 2.12: MRA (purple image) superimposed on LGE-MRI (green image)
before (left) and after (right) the registration.
Figure 2.13: Workflow of the registration step
The last step of the implemented workflow regards the fibrosis quantification.
The employed methods are described below.
Histogram-based reference This thresholding technique is based on the
histogram of the image. Normal tissue is defined automatically as the mean
of the lower region of the pixel intensity histogram (between 2 and 40% of the
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Figure 2.14: Schematic reconstruction of the 3D LA model with fibrosis distri-
bution superimposed.
maximum intensity within the LA wall). The threshold cut-off to detect the
fibrotic tissue is chosen at 2-4 SD above the mean of the normal tissue value
(Figure 2.15) [44]. Mathematically, it can be written as:
Thfibrosis = MNT +N · SDNT
where MNT and SDNT are the mean and standard deviation of the normal tissue.
Figure 2.15: Histogram-based reference
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Image intensity ratio The image intensity ratio (IIR) is a normalized mea-
sure to assess LA fibrotic tissue on LGE-MRI. The IIR normalizes myocardial
image intensities by the mean blood-pool intensity [40]. The IIR equation is the
following:
IIR =
SI
MPBP
where SI is the signal intensity, and MBP is the mean of the blood-pool. Dewire
et al. [86] used this method to detect pre-existent LA fibrosis and they dis-
tinguished normal tissue (IIR<0.97), abnormal myocardium (0.97<IIR<1.21),
fibrotic tissue (1.21<IIR<1.61) and dense scar (IIR>1.61).
Fibrotic tissue segmentation using graph cut The graph cut is a method
used for image segmentation that can be formulated in terms of energy mini-
mization. “Binary” problems can be solved exactly using this approach; prob-
lems where pixels can be labeled with more than two different labels cannot
be solved exactly, but the solutions are usually near the global optimum. The
output of the graph cut method is a binary data. A graph is a representation of
a set of objects, where several pairs of the objects are connected by links. In this
project, this method was used to segment the fibrotic tissue by treating each
pixel in the image as a node of the graph. Apart from these nodes, the graph
is composed by other extra nodes called “terminal nodes”, each representing an
object in the image. All the pixels are connected to all their adjacent pixels and
to the object nodes. In the binary problems, two terminal nodes, called back-
ground terminal and object terminal are used (Figure 2.16). For the fibrosis
segmentation, the two terminal nodes were defined as healthy myocardium and
fibrotic tissue, analogous to the image background and foreground of general
image segmentation problems.
In a graph G = (V,E), V and E denote the set of vertices and edges of G, re-
spectively. For the fibrosis segmentation we can consider a weighted graph with
two distinguished verticals terminal nodes. A cut C ⊂ E is a set of edges such
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Figure 2.16: A schematic implementation of the graph cut methods.
that the terminal nodes are separated in the induced graph G(C) = (V,E−C).
The cost |C| of the cut C is defined as the sum of its edges weights. It is possible
to consider each image voxel as a node in the graph and each of the voxel nodes
has edges that connect it to its neighbors (N-links), and the two terminal nodes
(T-links) [87].
A minimal cut generates a segmentation that depends on the definition of the
edge weights and on the choice of the energy function.
The energy function (EF) is defined as:
EF (L) = λ
∑
x∈X
Rx(Lx)︸ ︷︷ ︸
regional term
+(1− λ)
∑
(x,y)∈N
Bxy(Lx, Ly)︸ ︷︷ ︸
boundary term
where L = Lx|x ∈ X denotes a segmentation, X is the voxel set, N is the
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neighboring relations on the voxels. Rx is the regional term, which evalutes
the fit of the class membership (fibrotic tissue or healthy tissue) to the data
voxel intensities. Rx was obtained from the Gaussian mixture model to set the
regional term weights:
Rx(”healthy”) = −lnP (”healthy”|Ix) = −ln
(
pi1N(Ix|µ1,
∑
1)
p(Ix)
)
Rx(”infarct”) = −lnP (”infarct”|Ix) = −ln
(
pi2N(Ix|µ2,
∑
2)
p(Ix)
)
where, Ix is the intensity at voxel x, pi is mixture weighting coefficients, µ is the
mean intensity inside the healthy/fibrotic region, ,
∑
k is the covariance matrix,
N(·) is the Gaussian probability distribution. The boundary term Bxy evaluates
the penalty for edges between pixels (8-way connected neighborhood), and it is
defined as:
Bxy(Lx,Ly) =
e−β||Ix−Iy||
2
dist(x, y)
where, dist(x, y) is the Euclidean distance between voxel x and y, and β is the
penalty coefficient [87].
2.2.2 Results
The difficulties on LGE-MRI data acquisition not allowed a correct visualiza-
tion of the fibrotic tissue on the atrial wall in most of the data. Both healthy
and fibrotic tissue appear bright white in the images (Figure 2.17) and for this
reason the previously described models were tested on MRI data of DECAAF
study [43] provided by the CARMA Center thorough a free- access website.
The automated workflow for the fibrosis assessment was tested on ten patients
affected by AF. In-plane axial spatial resolution of both MRA and LGE-MRI
data is 0.65x0.65. The slice thickness was 1.25 mm (Figure 2.18) with no gap or
overlap between slices. The other scan parameters are described in Chapter 1.
Before segmentation, the MRA data were in the axial view. Registration was
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Figure 2.17: An example of LGE-MRI in which both healthy and fibrotic tis-
sue appears bright white.
Figure 2.18: An example of MRA image (left) and LGE-MRI (right).
applied to MRI data in axial view and the estimated affine matrix was used to
register the 3D LA surface obtained from the segmentation on the LGE-MRI
spatial domain. Finally, the grey intensity levels of the LGE-MRI were super-
imposed on the 3D model and the fibrosis was quantified (Figure 2.19).
Each quantification method was applied to the LA wall. The epicardium
identification was obtained applying the dilation operation to the endocardium
contours, taking into account the LA wall thickness.
Time required for the total analysis (from the MRA segmentation to the fibrosis
quantification) was about 15 min. The results of the fibrosis quantification esti-
mated using the methods previously described are reported in the Table 2.2. In
addition, patients were assigned to 1 of 4 groups (fibrosis stages 1-4) according
to the Utah classification.
As in the DECAAF study, the overall volume of the LA myocardium was calcu-
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Figure 2.19: Application of the implemented workflow for the fibrosis assess-
ment on the CARMA Center data.
lated as the number of the voxels within the endocardial and epicardial contours.
The extent of enhancement was then computed as the number of the pixels iden-
tified as enhanced by the methods over the volume of the LA myocardium for
the slice.
A qualitative result of the application of the graph cut method for the fibrosis
segmentation in one slice is shown in the Figure 2.20. An example of the volu-
Figure 2.20: Example of the result of the fibrosis segmentation (red regions)
on the LA wall obtained using the graph cut (right) in one slice (left). The
blue region represents the healthy tissue.
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metric percentage of the LA wall enhancement estimated by the three methods
in one patient is shown in the Figure 2.21.
Figure 2.21: top panel) 3D LA model obtained in one patient with the fibro-
sis information superimposed. Binary maps (bottom panel) that show the fi-
brosis percentage (white regions) on the 3D atrial surface estimated with the
histogram based reference method (left), with the IIR method (middle) and
using the graph cut for the fibrosis segmentation algorithm (right). In this ex-
ample all methods classified the patient in the Utah 2, despite the difference
on percentage of fibrosis estimation.
2.2.3 Conclusion and discussion
An automated approach for 3D visualization of the fibrotic tissue extent and
its quantification was developed. The implemented workflow was tested on ten
MRI data acquired at the CARMA Center that were assigned to 1 of 4 groups
(fibrosis stages 1-4) according to the Utah classification.
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Up to now no methods can be defined as “gold standard” for the fibrosis quan-
tification and this work highlighted the Utah classification strictly depend on
the selected method for the analysis. The IIR method detects smaller areas of
fibrosis than the other ones whose performance are similar. Since, the classifi-
cation of the tissue as normal, abnormal, fibrotic or dense scar was performed
following [86] and the image acquisition protocol is not standardized, this may
result in incorrect classification results. Unfortunately the availability of only
few data did not allow us to define different thresholds. In most cases, patients’
classification performed using the histogram-based reference method is the same
to the classification computed using the graph cut. The Mann-Whitney test was
performed and the statistical test showed the two classifications are not statis-
tically different (pi¡0.05).
Another important aspect is the correct segmentation of the LA wall. In the
DECAAF study the LA wall segmentation is manually traced by an expert but
the LA wall detection might be affected by the intra/inter observer variability.
Several methods have been developed automatically to quantify the LA wall
thickness from CT images. In [88], a segmentation of the wall in four regions,
inter-atrial septum, below right inferior pulmonary vein, appendage and anterior
wall was performed whereas [89, 90] chose to build a pipeline based on a mul-
tiregion segmentation method. However this task remains challenging, because
the LA wall is heterogeneous, thin, consisting of mix of granules and fibrosis,
especially in patients with myocardial diseases or persistent AF. Moreover, the
accuracy of the segmentation is also difficult to validate, as few manual segmen-
tations or reliable ground truths are available [91].
The results of the fibrosis quantification require further validation on a larger
population. However, based on our experience acquisition of LGE-MRI, strongly
relies on the radiologists experience and the merely application of the protocol
proposed in the DECAAF study does not directly imply good quality images.
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Histogram-based reference IIR method Graph-cut approach
Patient fibrosis (%) Utah Stage fibrosis (%) Utah Stage fibrosis (%) Utah Stage
#1 18.98 2 5.64 1 8.54 2
#2 31.55 3 6.31 1 21.77 3
#3 34.88 3 16.07 2 22.51 3
#4 18.93 2 15.72 2 11.62 2
#5 16.67 2 8.97 1 8.31 2
#6 43.56 4 2.70 1 26.07 3
#7 43.92 4 9.63 1 30.13 3
#8 24.94 3 8.92 1 12.65 2
#9 14.97 2 4.91 1 6.05 2
#10 24.70 3 4.55 1 13.45 2
Table 2.2: Results of the fibrosis percentage estimation and patients’ classifi-
cation obtained with the three methods. In this work, 5 SD was used in the
first method, and the threshold used to define the fibrotic tissue in the second
one was: 1.20<th<1.61. In the graph cut, β was 5, to increase the relative
importance of high gradient between pixels of different class and λ was 0.5.
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Chapter 3
Electrical characterization
of the LA in AF
In this chapter the methods designed and developed to characterize the LA elec-
trical activity are illustrated. In particular a new approach for the meandering
and stable rotor localization and detection on the 3D LA surface is described
and the results of its validation are showed. In addition, the use of different
catheters to acquire EGMs allowed us to derive some considerations about their
ability to map the LA and detect AF triggers.
Rotor ablation guided by the basket catheter mapping has shown to be ben-
eficial for AF ablation [57]. Yet, the initial excitement was mitigated by a
growing skepticism due to the difficulty in verifying the protocol employed by
the RhythmView R© system in locating electrical rotors. Overall, the underlying
assumptions of the FIRM protocol still need verification: i) AF is sustained by
stable rotors; ii) a rotor can be terminated by ablating its core; iii) the basket
catheter allows reliable rotor mapping. In this chapter, a fully-automated work-
flow for the rotor detection on the LA surface, based on the phase analysis of the
EGMs is described. The workflow was divided in two steps, oppurtunely vali-
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dated. The first one was the LAAT detection and 3D phase map construction.
For the LAAT localization on the EGMs a modified version of the SR method
[92] was implemented in order to improve its outcome. The developed approach
was validated using synthetic EGMs and their construction is illustrated in the
section 3.1.2.1. The second step was the development of the meandering and
stable rotor detection algorithm and its performance was tested using an atrial
computational model published in literature. In addition the persistence in time
of the detected rotors was computed. Finally, in order to verify the efficacy of
the basket catheter and its spatial coverage on the rotor detection, its perfor-
mance was compared with another catheter with a spatial resolution lower than
the Constellation.
3.1 Clinical data
Six patients with paroxysmal AF, aged 37 to 75 were enrolled in the study
at “M. Bufalini” Hospital, Cesena, Italy. All patients underwent an ablation
procedure and the Constellation catheter was used to acquire unipolar EGMs.
The registrations are 10s long and the sampling frequency is 2000 Hz. Digital
electro-anatomic atrial shells were created for clinical guidance using the NavX
mapping system.
The study was approved by the Ethics IRST, IRCCS AVR Committee (CEIIAV
n. 1456 prot. 6076/2015 I.5/220) and informed consent was obtained from all
the subjects.
3.2 LAAT detection algorithm and phase map
construction
Since it is well known [93] that the main problem of the basket catheter is its
coverage of the endoatrial wall, for the detection of LAAT we discarded the
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EGMs acquired by the electrodes whose position was farther than 13 mm from
the LA wall. This threshold was empirically fixed considering the electrophysi-
ologist’s suggestion.
The remaining EGMs were band-pass filtered (3 to 80 Hz) and far-field QRS
complexes were subtracted from the unipolar EGMs by a single-beat cancella-
tion method [94]. A template of the ventricular far-field potential was obtained
by averaging all time windows of the LA EGMs around R-wave peaks detected
in the ECG signals (Figure 3.1). The R-wave peak detection algorithm is based
Figure 3.1: Ventricular template estimation. Top panel: ECG signal with the
detcted R-wave peak (red dots). Ventricular template was obtained by averag-
ing the ventricular activations extracted from the EGM considering a window
250 ms long (red boxes). Bottom panel, left: EGM with the identified ventric-
ular activations. Bottom panel, right: An example of the obtained ventricular
template.
on the cross-correlation function which tests the similarity between a QRS com-
plex template and the ECG signal. The algorithm returns the maximal cor-
relations and the time shift related to them that corresponds to the R–wave
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peaks. Templates of the of VA were obtained by extracting windows of length
equal to 250 ms from the EGMs around the detected R-waves and the far-field
ventricular potentials were removed by substracting the template (Figure 3.2).
The implemented algorithm for the LAAT detection is a modified version of the
Figure 3.2: Top panel: ECG signal; middle panel: example of a EGM charac-
terized by both AAs and VAs; bottom panel: the same EGM after the ven-
tricular far-field removal.
electrogram recomposition from sinusoidal wavelets proposed by Kuklik et al.
[92]. The method uses the phase information of the recontructed signals for the
AA detection which correspondes to the position of the phase inversion (phase
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transition from pi to -pi).
The sinusoidal reconstruction of the unipolar EGM was obtained considering a
sinusoidal wavelet for each time point of the original signal on which the deriva-
tive is negative (Figure 3.3). The wavelet amplitude is proportional to the slope
of the signal and its period is equal to the mean cycle length of the EGM. The
mean cycle length was calculated by estimating the dominant period for each
signal as the inverse of the DF. The DF was computed considering the method
previously published in literature in [95]. Before estimating the power spectral
density using the Welch’s method, the Botteron’s approach was applied for each
signal [95]. This pre-processing consists in three steps: (1) band-pass filtering at
40-250 Hz, (2) absolute value, (3) low-pass filtering at 20 Hz. Since the patients
are affected by paroxysmal AF, the DF value was defined as the frequency with
the highest power in the range of 3-10 Hz. The recontructed signal is obtained
by summing the sinusaoidal wavelets and its phase results in a “sawthooth”
shape (Figure 3.3). The phase is estimated considering the AS whose imaginary
component is obtained applying the HT to the signal. The AS is a complex
signal whose negative components have zero amplitude.
AS(t) := u(t) + jH(u)(t).
where u(t) is the signal and H(u) is its HT. The HT is a linear operator
which takes a funcion f(t) and produces a function H(f)(t) in the same domain.
HT is the convolution between the Hilbert transformer and the function f(t).
H(u)(t) := f(t) ∗ hH(t) = 1
pi
∫ ∞
−∞
f(t)
t− τ dτ.
where:
hH(t) =
1
pit
.
The transfer function of HT is:
HT (ω) := −jsign(ω).
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Figure 3.3: Workflow of the sinusoidal recomposition of the EGMs. a) Orig-
inal signal. b) Generation of the sinusoidal wavelets in corrispondence of the
all negative deflections. c) Recomposed signal obtained from the sinusaoidal
wavelets. d) Phase of the recomposed signal.
where:
sign(ω) =

1 ω > 0
0 ω = 0
−1 ω < 0
HT produces a -90◦ degree phase shift for the positive frequency and a +90◦
degree shift for the negative. The amplitude do not change. The phase of the
signal is obtained from the AS:
φ = arctan
−f(t)
H(f)(t)
.
The SR method was tested on real clinical data acquired during RFCA using
the basket catheter. The obtained results were not satisfactory, especially in
presence of noisy signals. In some cases, the detected phase inversion do not
correspond to the real AAs (Figure 3.4). Since, a correct AA localization is
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Figure 3.4: An example of the result on a portion of EGM (2400 ms) obtained
applying the SR method. The red line represents the phase estimated on the
reconstructed signal. The detected AAs (black dots) were compared with the
manual annotations performed by the expert (red dots). In this case, five AAs
were not correctly identified by the algorithm.
important for indentifying and quantifying the spatiotemporal organization of
AF, a modified version of the SR method was developed in order to improve
its outcome. In the proposed approach, considering a typical morphology of an
atrial activation, the wavelets were only generated in correspondence of all neg-
ative derivative points that satisfy some conditions. For this purpose, additional
constraints, empirically selected, for sinusoidal wavelet generation were taken
into account, by adding some thresholds on the slope of negative deflections (≤
-0.012 mV/ms), on their amplitude (≥ 0.034 mV) and on their duration ([50-80]
ms). The HT was applied to the reconstructed signals and the resulting phase
inversion points were used to center a window with the length proportional to
the dominant period, in which the point with the maximum negative derivative
was considered as the LAAT (Figure 3.5). This new method was named NDSR.
Figure 3.6 shows the result of the application of the NDSR method on the same
portion of the EGM shown in Figure 3.4.
Once the LAATs were detected, 3D phase maps were constructed on the por-
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Figure 3.5: Schematic workflow of the NDSR method. The sinusoisal wavelets
are generated considering the additional thresholds on negative deflections.
Around the phase inversions, the maximum negative derivative point is esti-
mated and correspondes to an LAAT.
Figure 3.6: Result of the application of the NDSR method. Only two LAATs
were incorrectly classified.
tion of the 3D geometry of the LA covered by the catheter. To each point on
the anatomy was assigned the phase value computed considering the signal from
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the nearest electrode (Figure 3.7)
The interpolation between nearby electrodes was not considered in our analysis.
A first attempt we decided to use for the rotor localization only the original
signals and not to introduce additional informations that might influence the
analysis. This choice is supported by a recent study conducted by Martinez
-Mateu et al. [96] demonstrated how the phase interpolation can bring to the
generation of phantom PS points on the basket maps. For the validation of the
Figure 3.7: An example of 3D phase map reconstruction in one patient and in
one frame. The grey regions represent the portion of the LA not covered by
the catheter.
NDSR algorithm, as first attempt, the LAATs were compared with the manual
ones performed by two experts. Unfortunately manual annotation of LAATs is
a time-consuming and challenging process which suffers from high intra/inter-
observer variability (Figure 3.8). Therefore an approach based on synthetic
signals in which LAAT positions are known, was used for the proposed algo-
rithm validation.
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Figure 3.8: Manual annotations performed by the physicians (red and blue
dots) on a real EGM without the ventricular activations. In this example, the
agreement was found only for 20 LAATs.
3.3 Synthetic EGM generator
The content of this paragraph is based on the article “Towards a repository
of synthetic electrograms for atrial activation detection in atrial fibrillation”,
by Maddalena Valinoti, Francesca Berto, Stefano Severi, and Cristiana Corsi,
which was submitted to Computer Methods and Programs in Biomedicine. The
SEGMs generated for the NDSR method validation were provided as supple-
mentary material.
PhysioNet offers free web access to large collections of recorded physiologic
signals including ECG and related open-source software. Researchers on ECG
analysis take advantages of such resources to test new methodologies and share
data and algorithms for data analysis. Several dynamic approaches have been
proposed for modeling synthetic ECGs in heterogeneous conditions and with dif-
ferent PQRST-complex morphologies [97, 98]. Unfortunately, no atrial unipolar
EGMs in the left atrium, not from real patients or synthetic are available in
68
PhysioNet and no models have been proposed for simulating realistic EGMs
derived directly from the real ones.
For this purpose a new and fast workflow for the generation of realistic SEGM
in AF condition with different levels of noise and at different AF rates was
proposed. In addition the SEGM signals will be shared with the scientific com-
munity as a first step towards a repository of synthetic and real atrial signals
supporting the evaluation of new approaches on the same database to allow
direct comparison between them.
Material and Methods The SEGM generator was constructed starting from
the clinical data and the manual annotations performed by the experts. A subset
of 19 real EGMs characterized by different AA patterns was visually selected for
the SEGM generation and an example of the selected signal after the band-pass
filtering and far-field QRS complex substraction was shown in the Figure 3.9.
It is well known that both atrial and ventricular activity can be recognized
Figure 3.9: One of the 19 signals selected for the SEGM generation after the
VA removal.
on a real EGM. Therefore, the SEGM was designed including these two main
components (AA(t) and VA(t) respectively):
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SEGM(t) = AA(t) + V A(t).
VA(t) represents a noise superimposed to the atrial signals, due to the far field
effects of the ventricles especially during their depolarization phase. The atrial
activity can be seen as the sum of two subcomponents:
AA(t) = Afar(t) +Anear(t).
where Afar(t) is the far field effect that interferes on Anear(t) that represents
the LAAT, hence the actual signal of interest. The Afar component represents
signals from far sources that result in the noisy effect usually overlapped to
the near field activity. This component was modeled using an autoregressive
(AR) model. The AR model is based on the hypothesis that a time series can
be considered as the output of a linear filter whose input is white noise. The
current sample of the process is expressed as the sum of the weighed previous
values and a noise component:
Afar(t) =
p∑
k=1
ckAfar(t− k) + w(t).
where w(t) is the white noise given in input to the model; p is the order of
the model and ck its coefficients [99, 100]. The coefficients and the variance of
the white noise were estimated by applying the Yule-Walker equations based
on the evaluation of the autocorrelation function. The Yule-Walker equations
entail the recursive computation of the autocorrelation function r(s) of the AR
process with the lag s0:
r(s) =
p∑
k=1
ckr(s− k) + δ(s)σ2.
where δ(s) is a discrete impulse and σ2 is the variance of the white noise. The
coefficients ck and the order p were derived by fitting the 19 EGMs as explained
in the following. Afar corresponds to each segment of the real EGMs between
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two annotated atrial depolarizations. AAs were excluded considering a 80 ms
window around the maximum negative derivative of the manually annotated
activations. The window length was set considering the typical morphology
of an atrial activation and to ensure the activation patterns are completely
excluded from the atrial far field template. Segments shorter than 150 ms were
discarded. Each segment was then fitted by an AR model of order p, with p in
the range [1- 40]. The optimal order p for each segment was obtained minimizing
the Akaike’s information criterion (AIC):
AIC(p) = nlog(σ2p) + 2p. p=1,...,40
where n is the length of the segment and σ2p is the variance of the white
noise at the order p. The optimal order p for each signal was estimated by
averaging the order p for each segment and it was used to re-compute the ck
and σ2p for each segment. For each EGM these coefficients and the variance
were used to compute Afar. The proposed approach for Afar construction is
depicted in Figure 3.10 (a-b). The Anear component was extracted from the
19 real EGMs considering the electrophysiologists’ agreement on LAAT detec-
tions. Each extracted atrial template was multiplied by a cosine function in
order to smooth the extremities and avoid sudden transitions at the beginning
or the end of each template that may cause spurious atrial activation patterns
into the SEGM. In addition, for each template, its mean value was subtracted.
Figure 3.10 (c) shows an example of atrial template derived from a real EGM
(Figure 3.10 (a)).
The template locations on the Afar signals were assigned considering that the
intervals between successive activations can be described by a gamma distribu-
tion. The gamma distribution is a probability function defined by a scaling (θ)
and a shaping (s) parameter that can be estimated considering the following
equations:
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Figure 3.10: Workflow designed for the atrial component construction. (a) Ex-
ample of atrial segments extracted from the real EGM and used to estimate
the AR model. The AAs were excluded considering windows 80 ms long (red
box) around the maximum negative derivative points of the manually anno-
tated activations (red dots); (b) Output of the AR model that represents the
Afar signal; (c) Anear component.
sθ = mean(IT )sθ2var(IT )
The mean and the variance of the atrial periods (IT) were directly derived
from real EGMs and set to 250 ms and 992 ms2 respectively; the computed
parameters were: s= 62, θ=4.
The atrial templates were randomly selected and located on the Afar signal
through the gamma distribution.
The ventricular component to be located on the synthetic signals were obtained
considering the extracted windows from the real EGMs with the length equal
to 250 ms around the detected R-waves. This value that may be considered
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rather long, was set to be sure to exclude the atrial activity corresponding to
the entire QRS complex.
To place the ventricular far- field potential on the SEGM composed by the Afar
and Anear components, an atrio-ventricular (AV) node model was used. The
model takes in input the atrial rate [101] and gives as output the instants of
time in which ventricular activity starts. These instants were used to place the
VA templates in the signal already composed by the Afar and Anear components.
The completed workflow describing SEGM generation is shown in Figure 3.11.
For each SEGM, all components (Afar, Anear and the VA) come from the same
real EGM. Six sets of 50 SEGMs characterized by an increasing level of noise
were generated by modifying the values of the variance of the white noise (σ=aσ,
with a= 0, 0.1, 0.2, 0.5, 0.7, 1) used as input to the autoregressive model. An
additional set of 50 SEGMs was generated considering a varying value for the
variance of the white noise, a=f(Anear), based on the amplitude of the atrial
activations of the real EGMs with the aim to reduce the variance if the amplitude
is too small.
Data Analysis The realism of the synthetic EGMs was assessed by three
electrophysiologists. A dataset of 50 EGM signals (25 SEGMs and 25 real
EGMs) was built for this visual evaluation. The 25 SEGMs lasting 2 seconds
were randomly selected from the set of 350 SEGMs generated as previously
described. The experts were asked to indicate which signals were real and which
not. After 2 weeks the experts repeated the analysis on a randomly selected
subset of 21 signals belonging to the same set of 50 EGMs previously evaluated.
This set included 10 EGMs and 11 SEGMs. Sensitivity, specificity, positive
predictive value and negative predictive value were computed considering the
expert indication on the 50 signals; agreement in repeating the same choice (real
or synthetic signal) was also evaluated.
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Figure 3.11: Complete workflow designed for SEGM generation.
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TP FN FP TN SE PPV SP NPV
Expert1 17 8 6 19 68% 74% 76% 70%
Expert2 20 5 21 4 80% 49% 16% 45%
Expert3 7 15 15 10 28% 32% 40% 40%
Table 3.1: Results of EGM classification. TP=true positive; FN=false neg-
ative; FP=false positive; TN=true negative; SE=sensitivity; PPV=positive
predictive value; SP=specificity; NPV=negative predictive value.
Results The time required to generate the synthetic EGMs was less than
1 minute once annotated EGMs are available. The sampling frequency of the
generated SEGMs is 2000 Hz. An example of one real EGM (a) and three derived
synthetic EGMs with different level of noise (b-d) is shown in Figure 3.12.
In Table 3.1, are reported the results of the analysis performed by the three
experts in judging EGMs. Expert #3 was not able to judge three EGMs and
was not able to explain the reason. An example of an EGM that was correctly
identified as synthetic by the three experts is reported in Figure 3.13 (top panel)
together with an example of a real EGM in which the three observers were not
in agreement (bottom panel). When experts repeated the analysis on the 21
signals after two weeks, expert #1 agreed with his previous annotations in 15
signals, of which 8 were annotated as real and 7 as synthetic. The 8 EGMs
classified as real included 4 real EGMs and 4 SEGMS; the 7 signals recognized
as SEGMs included 1 EGM and 6 SEGMs. Expert #2 agreed in recognizing the
entire dataset as 19 real and 2 synthetic signals. The 19 real EGMs included 10
EGMs and 9 SEGMs; the 2 signals recognized as SEGMs included 1 EGM and
1 SEGM. Expert #3 agreed in recognizing 11 signals of which 6 were annotated
as real and 5 as synthetic. The 6 real EGM included 1 EGM and 5 SEGMs; the
5 signals recognized as SEGMs included 3 EGM and 2 SEGMs.
Discussion This is the first study aimed at the generation of synthetic unipo-
lar electrograms in AF.
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Figure 3.12: SEGMs with different levels of noise ((b) 10%, (c) 50%, (d)
100%), obtained starting from the real EGM shown in (a).
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Figure 3.13: Top panel: example of a SEGM correctly identified by the three
observers in each test; bottom panel: example of real EGM characterized by a
high intra/inter observer variability.
EGMs were generated as the sum of two contributions due to atrial and ven-
tricular activities, directly derived from real EGMs that have been manually
annotated. Results showed the synthetic EGMs are realistic and electrophysi-
ologists were not able to distinguish them from real EGMs.
Expert #1correctly recognized 72% of signals; this percentage decreased to 48%
and 34% for expert #2 and expert #3 respectively. On the entire dataset, the
three experts classified as real EGMs 46%, 82% and 44% of signals, confirming
high variability between experts. In this group of “real recognized” EGMs, 26%,
51% and 68% were SEGMs for expert #1, #2 and #3 respectively. For the three
experts 24%, 84% and 60% of SEGM were misclassified and considered real.
Based on the results on repeatability of annotations, two out of three electro-
physiologists reported high reproducibility percentages in the two sessions (72%
and 100% respectively); however, in the EGM annotations, 50% of real signals
were incorrectly classified by expert #1 as false positive. Expert #2 classified
91% of EGMs real including 50% of incorrect classification for both real and
synthetic signals. EGMs are characterized by a huge variability depending on
the level of noise and the position of electrodes, therefore these results are not
77
surprising. Expert #3 seemed to perform the choises almost randomly, con-
firming how synthetic signals look like real signals. Overall, based on these
results we can state synthetic EGMs look realistic. The only approach designed
to reproduce realistic EGMs is the one proposed by Rivolta et al. [100]. In
their study, both near field atrial activity and ventricular activity contributions
are obtained by summing up the potentials generated by a dipole moving in a
uniform infinite medium along specific directions.
The choice to directly derive these contributions from real EGMs allows us not
to add potential unrealistic approximation due to the use of the dipole modeling
to simulate the propagation complex signals. Differently from their algorithm
we focused on the AF condition and we generated signals representative of dif-
ferent levels of noise as it happens in real conditions in different patients.
The developed workflow is effective and could be easily adopted to generate
SEGMs in different arrhythmic conditions (persistent AF, atrial flutter, ..) start-
ing from real EGMs and allowing to reproduce their inter-subject variability,
for example, in morphological aspects of atrial activations, also including frac-
tionated EGMs. Moreover, for each considered pathological condition, model
parameters may be tuned to describe different atrial and ventricular rates and
far field noise. In the present study real EGMs from patients with paroxysmal
AF were analyzed but the same approach might be applied to other arrhythmic
conditions. Obviously this statement should be proved but no theoretical con-
straints limit the application of our approach to EGMs of patients affected by
different kind of AF.
In addition, the proposed workflow could be further simplified for the ventric-
ular activity step since a realistic sequence of RR intervals obtained from real
signals could be used to locate the ventricular far-field instead of using the AV
node model.
The model is stationary respect to the near field and atrial activation frequency
but this work wants to provide a dataset to facilitate the comparison of different
signal processing techniques. Similar approaches have been proposed in recent
years for different bio-signals in the mono- bi- and three-dimensional domain,
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including ECG [98], echocardiographic data [102], EMG [103].
Using such synthetic signals, the performance of a given technique, can be pre-
sented and such performance assessment could be used as a “standard” and
would enable clinicians to ascertain which biomedical signal processing tech-
niques is the best for a given application. In the field of AF the availability of
“standard” synthetic EGMs is particularly crucial. Indeed, variability in atrial
activation detection in real EGMs is huge.
The manual annotation of LAATs by two electrophysiologists resulted in a very
poor agreement. In nineteen EGMs of 10 s duration each, The manual annota-
tions resulted in the detection of 443 LAATs from physician #1 and 534 LAATs
from physician #2. Only 177 LAATs were detected by both observers consid-
ering a windows of 80 ms. Consequently, differently from other fields in which
manual detection is considered the gold standard, for this specific analysis it
results unreliable.
The seven sets of 50 SEGMs we generated using the described approach will be
available for the scientific community. Seven .mat files were provided together
with the “true” LAATs and the R-wave peak locations.
Since nowadays, a large research effort is devoted to better understanding the
mechanisms underlying AF and a correct LAAT detection is crucial for AF
drivers localization, this study contributes to standardize the validation of the
numerous approaches designed and tested for AF driver detection.
3.3.1 Validation of the NDSR method on SEGMs
The NDSR method was tested on SEGMs and the detected LAATs were com-
pared with the ground truth atrial activations (Anear). The first set of SEGMs
was excluded from the validation analysis since it is characterized by zero level
of noise and does not represent a real condition. The results of the validation
are shown in the Table 3.2. A detection was considered successful if it matched
the Anear within a window of 50 ms.
As expected, the results of the validation showed that the performance of the
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# TA EA TP FP FN PPV (%) Se (%)
1 2049 2054 1892 162 157 92 92
2 2048 2000 1832 168 216 92 89
3 2000 2058 1765 293 235 86 88
4 2049 2128 1629 499 421 77 79
5 2000 2084 1399 685 605 67 70
6 2000 2110 1254 852 742 60 63
Table 3.2: Quantitative results of LAAT detection on synthetic EGMs for
increasing levels of noise. TA: true activations; EA: estimated activations;
TP= true positive; FP/FN=false positive/negative; PPV= positive predictive
value; Se=sensitivity.
algorithm on LAAT detection on SEGMs is high when the level of the noise
is low. Nervethless, the performance of the algorithm remains accurate also in
presence of a high level of the noise.
The SR method was also tested on the same dataset composed by 350 SEGMs
in order to compare the performances of the two methods. The results of the
SR application of the SEGMs are shown in Table 3.3. The two techniques
reported similar value of PPV and Se for low levels of noise, up to k=0.2 the
PPV and sensitivity of the SR method were systematically lower up to 10%.
3.4 Rotor detection algorithm
The rotor detection algorithm is based on the search of the PS points. PS is
a point surrounded by a gradual phase transition between neighbouring points
up to an inversion phase ( from pi to -pi). The classical approach using for PS
detection is based on closed path integral of the phase gradient:
∮
c
∇ϕd−→l .
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# TA EA TP FP FN PPV (%) Se (%)
1 2049 2116 1864 252 185 88 91
2 2048 2075 1892 156 183 92 91
3 2000 2074 1674 400 326 81 84
4 2049 2171 1522 649 528 70 74
5 2000 2147 1242 905 759 58 62
6 2000 2192 1096 1096 904 50 55
Table 3.3: Quantitative results of LAAT detection on synthetic EGMs ob-
tained with SR method. TA: true activations; EA: estimated activations;
TP= true positive; FP/FN=false positive/negative; PPV= positive predictive
value; Se=sensitivity.
where c is a closed loop surrounding the given point, ϕ is the phase value in
space, ∇ is a spatial derivative. PS is detected if, taking the consecutive phase
differences between neighboring points moving along the path c, there is only
one large phase difference corresponding to the transition to a new cycle.
In case of a discrete mesh of electrodes such as the Constellation catheter, the
integral has to be discretized and approximated. The loop c becomes a ring
of electrodes encircling a point that could be a PS point [104]. An example
of 2x2 ring of electrodes and a PS point on 2D spatial domain are shown in
the Figure 3.14. The implemented algorithm is able to detect PS points in 3D
domain. To each region of the LA mesh, the neighboring ones were estimated
and the phase gradient between them was computed (∇φ). If the region under
investigation is surrounded by a gradual phase transition between its neighbor-
ing regions plus an inversion phase, the mean point of their centroids represents
a PS point.
Since, for each time frame, the algorithm might detect several PS points due
to the discretization and the catheter resolution, a PS point was defined as the
pivot of a rotor if its lifespan is greater than one AF cycle (Figure 3.15). In
addition, the rotor was defined stable in the space if the coordinates of its pivot
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Figure 3.14: (a) PS detection using 2x2 ring of electrodes. (b) 2D phase map
of large rotating wave with its PS point (white dot).
(or PS point), remains inside a region of radius equal to 0.5 cm throughout its
lifecycle. Otherwise, the rotor was defined meandering. For each detected stable
Figure 3.15: Phase map reconstructed in one patient and in one time frame.
The map was obtained as described at page 65. The white arrow indicates
one detected stable rotor and the white dot represents its pivot. In this exam-
ple the AF cycle is 250 ms.
82
or meandering rotor, its persistance in time was also calculated considering the
threshold 0.5 cm on the maximum distance between the coordinates of its phase
singularity points estimated frame by frame.
The rotor detection algorithm was validated using an atrial computational model
and preliminary results are shown in the following section. This part of the
project was developed in collaboration with the Karlshrue Institute Technol-
ogy (KIT) in Karlshrue, Germany and received the funding from MIUR-DAAD
Joint Mobility Program, 2016-2017.
3.4.1 Validation of the rotor detection algorithm
A computational model of LA electrophysiology was used as benchmark for the
rotor detection algorithm validation. The 3D LA anatomy was derived from
the pre-operative MRA data using the new segmentation method of the LA
described in the Chapter 2. The atrial anatomy was converted into a cubic
lattice for the simulation. Atrial activation was simulated on the 3D anatomy
using the monodomain approach [105] and a variant of the Courtemanche et
al. action potential model, accounting for spatial heterogeneity and AF related
ionic remodeling [106]. Sinus activation was simulated by pacing the model at
the insertion point of the Bachmann bundle and at the Fossa Ovalis with a
physiological delay of 26 ms. Reentry was initiated by placing an extra stimulus
in a circular area of tissue of radius 10 mm. One meandering rotor was generated
on the posterior wall (Figure 3.16 (a)) and the simulation was 2s long. Sinus
activation was applied once and then suspended. EGMs were simulated by using
the assumption of an infinite homogeneous medium[107]:
Φ(P, t) ∝
∫
V ol
I(Q, t)
||P −Q||dQ.
where φ is the electric potential, P the sensing position and I the transmem-
brane current at each position Q within the myocardium. Sampling frequency
was 1000 Hz.
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Figure 3.16: Schematic workflow of the rotor detection applied on the simu-
lated data.
For the validation, a 2D grid in contact to the atrial wall, composed by 9x9
electrodes with 3 mm as intra-electrode spacing was generated (Figure 3.16 (a))
. On the simulated atrial EGMs the processing described so far was applied.
The simulated AF frequency was 7.8 Hz. The signals were band-pass filtered
(3-80 Hz) and then the NDSR algorithm was used for the LAAT detection (Fig-
ure 3.16 (b)). The 3D phase map was reconstructed and the PS points were
detected (Figure 3.16 (c)). The simulated rotor was correctly identified consid-
ering the PS with lifespan greater than 128 ms (Figure 3.16 (d)). As highlighted
in Figure 3.17, the detected pivot is close to the real one. In addition the tra-
jectory of the pivot of the rotor detected with the algorithm was compared with
the simulated one and the result is shown in the Figure 3.18. The trajectory
of the simulated rotor was manually traced. The centroids of the trajectories
were estimated and the distance between them was computed and was 3.6 mm.
The trajectory of the detected pivot is influenced by what we called the “border
artifacts” of the grid. The LA surface is divided in regions, each one associated
to the EGM acquired by the closest electrode. The regions closer to the grid
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boundary are bigger since they are not shared between neighbouring electrodes.
When we compute the PS pivot coordinates, these regions weight more than the
smaller ones and therefore the trajectory of the pivot results enlarged towards
this regions as shown in Figure 3.18. Preliminary comparison with the rotat-
Figure 3.17: Action potential map of the simulated rotor (left) and the phase
map reconstruction (right) in the same frame. The red dot in the both figures
represents the coordinates of the pivot detected by the algorithm.
Figure 3.18: top panel) Trajectory of the real pivot of the rotor. bottom
panel) Trajectory of the detected pivot.
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ing waves generated by the computational model showed correct identification
of the PS point. The distance between the centroids of the “real” pivot and
of the detected one is negligible respect to the typical size of an ablation (<1
cm2) and therefore the rotor detection algorithm seems to be able to provide a
correct information about the region to ablate for the rotor activity block.
We performed additional tests including more than one rotors, not necessarily
centered in the grid. Results showed the estimate is reliable only for rotors well
centered with the catheter and therefore a complete coverage of the rotor is
ncecessary for its identification.
In addition, in order to study the effect of the distance to the atrial wall, a set
of “toy” catheteters were generated and placed at different distances from the
wall (0.5 cm, 1 cm, 1.5 cm) (Figure 3.19) As intuitively expected, an increase in
Figure 3.19: Grid catheter placement. The grid is first computed in a 2D co-
ordinate system and then adapted to the 3D atrial geometry. The different
colors represent grids at different distance from the wall: green (contact); ma-
genta (0.5 cm); cyan (1cm); orange (1.5 cm).
distance implies an increased sensitivity to “far-field” effects (i.e. coming from
regions other than the mapped one). Results in rotor identification was correct
up to 0.5 cm with a distance between the centroids equal to 1.2 mm; at 1 cm,
the algorithm was not able to detect the rotor for all its lifespan (2s). A wall
distance of 1.5 cm is obviously too large for a reliable phase computation and
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with this setting the algorithm was not able to detect the simulated rotor.
The developed technique may provide a tool for investigating the effects of dif-
ferent catheter coverage, and of the intra-spline distance on the rotor detection.
3.5 Analysis of the influence of the catheter cov-
erage on the rotor localization
As mentioned in the Chapter 1, considering the basket’s size more used in clini-
cal practice, the covered area by the Constellation catheter is wide and is about
117 cm2. For the evaluation of the catheter coverage on the rotor detection,
the implemented workflow was applied on EGMs acquired by the PentaRay
catheter (Biosense Webstern, CA, USA) in five paroxysmal AF ablation proce-
dures. The PentaRay is composed by 20 electrodes located in five splines and its
coverage is 7 cm2 (Figure 3.20). The two steps of the workflow implemented for
Figure 3.20: PentaRay catheter.
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the LAAT and rotor localization were tested on PentaRay data. An example
of the obtained result is shown in the Figure 3.21. The results on the rotor
Figure 3.21: Example of phase maps (right) in four different frames obtained
from the EGMs acquired by the PentaRay catheter. The white arrow indi-
cates the detected rotor for each frame based on the phase information of the
signals (left).
detection obtained by the two catheters on the clinical data were compared
(Figure 3.22). Considering 13 mm as maximum distance between the electrodes
Figure 3.22: LA geometry with the catheter coverages (coloured regions, A)
35.0%, B) 11.0%) and one detected stable rotor (white arrow).
and the atrial wall, the computed coverage of the basket and PentaRay catheter
was: 43.3±7.8% and 12.3±2.4%, respectively. The dominant frequency esti-
mated and used for the sinusoidal recomposition method was 4.0±0.3 Hz for
the Constellation acquisitions and 4.2±0.2 Hz for the PentaRay ones. The
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number of stable and meandering rotors per subject detected with the basket
catheter was 4.0±3.4 and 4.6±5.0, with a persistence in time of 303.2±58.2 ms
and 302.3±52.0 ms, respectively. The PentaRay catheter identified 3.7±4.4 sta-
ble rotors with a persistence in time 326.0±215.2 ms and no meandering ones.
Preliminary results showed the presence of stable and meandering rotors in the
LA, characterized by a very short persistence in time. LA chamber coverage
has a central role for meandering rotor detection and the effects of the number
of the electrodes and their spacing are major challenges during AF mapping for
rotor detection.
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Chapter 4
Concluding remarks and
future developments
In this doctoral thesis, new approaches for the structural and electrical charac-
terization of the LA we presented, with the aim to support the investigation of
the maintaining mechanisms underlying AF.
In Chapter 2, a unified and fast workflow for 3D patient-specific LA models
computation (with and without PVs) was presented. The implemented models
might be useful to support patient selection for RFCA and provide a reliable
guidance during the therapy. The implemented approach based on a new seg-
mentation method of the LA, proved to be effective and provides a reliable 3D
LA models and an accurate LA volume estimation.
In additon, a fully automated approach for LA fibrosis quantification was de-
signed and developed. In particular a 3D LA fibrosis patient-specific model was
constructed and fibrosis quantification methods were implemented. The work-
flow was tested in ten patients which were classified in four stages according to
the Utah classification. The obtained results demonstrated that the classifica-
tion is influenced by the method applied for fibrosis assessment and a unique
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and reproducible threshold to define the fibrotic regions is still lacking probably
due to absence of a standardized LGE-MRI acquisition protocol.
In Chapter 3, a new approach for meandering and stable rotor localization and
detection on the 3D LA surface is illustrated. This is the first study which aim
to detect stable and meandering rotor in 3D domain. The workflow consisted
in two steps: 1) LAAT indentification and phase map construction, 2) PS point
estimation and rotor detection.
For the LAAT recognition, we designed an improved version of the SR method.
This new approach was validated using SEGMs with different level of the noise.
As expected, the results of the validation showed that performance of the new
method is high when the level of the noise is low. However, the performance
of the new algorithm remains accurate also in presence of a high level of the
noise. The SR method was tested on the same dataset of the SEGMs and the
performance of the mehod were systematically lower than the NDSR up to 10%.
To generate SEGMs with different levels of the noise and rates in AF, a new
workflow based on the real EGMs was proposed. The realism of the synthetic
EGMs was assessed by three electrophysiologists. Results showed the synthetic
EGMs are realistic and electrophysiologists were not able to distinguish them
from real EGMs.
The rotor detection algorithm was validated using an atrial computational model
and preliminary comparison with the simulated rotating waves showed correct
identification of the PS point. The proposed algorithm is able to provide a cor-
rect information about the region to ablate for the rotating pattern block. In
addition, the influence of the spatial coverage on the rotor localization was inves-
tigated comparing the results obtained with the PentaRay and the Constellation
catheters in clinical settings. Preliminary results showed the importance of the
spatial coverage of the LA for the meandering rotor localization. The identified
rotors by both catheters were characterized by a very short persistence in time.
Future developments of this project include the investigation of the relationship
between the LA enlargement and AF recurrence and testing the implemented
approach for the fibrosis assessment on a larger population.
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Acquisitions of more data using both PentaRay and Constellation are required
in order to better investigate the importance of the catheter coverage and the
intra-electrode spacing on rotor localization.
The integration of the new approaches developed in this work for structural and
electrical characterization of AF is part of the research in the near future, to
investigate the role of rotors and spatial relationship between them and atrial
fibrosis.
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